I have gotten a few PM's with questions and I wanted to share my replies on this board:
- I was asked my thoughts on the cause of the recent volume: One strong possibility is KB Medical. They were to receive $900K worth of stock. If I use a $.25 share price that would be 3.6 million shares. With that amount of shares maybe they were able to get a broker/clearing house to sell shares for them ( at least one friends and family participant has stated he has been unable to locate anyone to handle selling the private placement shares since the 211 has not been accepted yet).
- I was asked if the CareClix acquisition or 10Q could be delaying the 211: When I spoke to Glendale on 9/26 and learned that they received and answered the first round of questions I asked about the questions FINRA had. I specifically asked if the 10Q being late played any part. They said no. I asked if they had any questions about the Careclix acquisition. NO. I asked if they had any questions about the Careclix not being audited. NO I asked if they were asked to provide a NOBO list to FINRA. NO.
When I spoke to Glendale on 10/24 (second round of questions). I asked similar questions to see if the CareClix acquisition came up. NO
- I was asked about others posting that they contacted Glendale and were given a 2/3 month timeframe for the 211. All I will say is I trust the information I have been given from the person directly handling the 211 ( he is the person who filled out the 211, calling FINRA to check status, amending the 211, etc.). With Glendale handling lots of 211's maybe the party line for callers is a generic answer...I don't know. But I do know if you are going to do DD it is best to get to the source/person in the know. Knowing what roll the person plays/responsibility should be asked when given information so you can assess likely validity/accuracy.